SlideShare une entreprise Scribd logo
1  sur  14
RECENT DEVELOPMENTS IN THE
TREATMENTS OF
ATHEROSCLEROSIS.
1
WHAT IS ATHEROSCLEROSIS?
 Atherosclerosis (or arteriosclerotic vascular
disease) is a condition where the arteries
become narrowed and hardened due to an
excessive build up of plaque around the artery
wall.The disease disrupts the flow of blood
around the body, posing serious
cardiovascular complications.
2
WHY SHOULD WE KNOW ABOUT
ATHEROSCLEROSIS?
 Statins are highly effective in lowering low-
density lipoprotein (LDL) cholesterol levels,
and therefore represent the first-line
treatment for prevention of cardiovascular
disease. Despite this, a substantial proportion
(>50%) of high-risk patients do not meet
guideline targets for LDL cholesterol
reduction.This clearly indicates an unmet
need for additional treatment to improve LDL
goal achievement.
3
 Although atherosclerosis usually manifests in
later life, its early phases are present in
teenagers and young adults.
 The clinical manifestations of atherosclerosis,
such as CVD, are common in Western and
urban populations, and are an important and
common cause of death and disease.
 Statins produce significant toxicity at high
doses in a variety of animal species.
4
 Effects can be prevented by administering
mevalonate, the product of the reaction
catalysed by HMG-CoA reductase.This indicates
that these toxic effects are mostly, if not entirely,
attributable to extreme inhibition of the enzyme
at high doses.
 The risk of myopathy with statins is increased by
concomitant administration of certain other
drugs, particularly gemfibrozil and to a lesser
extent, possibly some other fibrates, and niacin.
5
6
TREATMENT:
 1)HDL usage : Boosting HDL cholesterol’s
role as an ally against heart disease. However,
the failure and increased mortality rates of
one HDL-raising trial drug, torcetrapib, in
2006 highlights the challenges of discovering
the right therapy.
7
 It has raised concerns that maybe it’s not
raising the right kinds of HDL. All forms of
LDL are bad, HDL is a much more
complicated story.HDL is called the “good
cholesterol,” but in truth, HDL particles vary
in size and composition, and we don’t know if
all forms of HDL are good.
8
9
 2)Anti inflammatories: Inflammation plays a key
role in plaque formation and subsequent plaque
rupture, which can lead to a heart attack. Statins
along with lowering LDL cholesterol have anti
inflammatory effect which help in preventing the
atheromatous plaque rupture.
 But, we have to develop entirely new types of
drugs that specifically prevent or reduce
inflammation in artery walls, by attacking root
causes.
Immunotherapeutic
approaches:
1) Lipid BasedVaccines: This approach involves
the inhibition of atherosclerotic lesion
formation, associated with increased CETP
antibodies, decreased CETP activity, and
modified lipoprotein profiles.
10
 2)VaccinationStrategies Based on Epitopes of
Oxidized LDL: The different epitopes of oxidized LDL
(oxLDL) induce atherogenic immune responses.This is an
effective tool for modulation of the immune response to
oxLDL.Also, a number of studies have shown that
immunization against oxLDL reduces atherosclerosis.
11
 Immunization with a peptide of apoB-100 (p210)
fused to the B subunit of cholera toxin (CTB), which
binds to a ganglioside on mucosal epithelia for 12
weeks, caused a 35% reduction in aortic lesion size in
atherosclerosis-prone apoE-deficiency.
 3) Heat Shock Proteins:Autoimmunity to heat shock
proteins (HSPs) is one element in atherosclerosis-
induced immune responses. Repeated mucosal
administration of Mycobacterium HSP60/65, both
orally and nasally, inhibited atherosclerotic lesion
formation in LDL-receptor-deficient mice.
12
CONCLUSION:-
 In order to reduce further myocardial deaths
we have to find safer and effective
treatments methods against atherosclerosis
and thereby reducing mortality and
morbidity.
 Right drug for the given condition.
 Atherosclerosis can be prevented by lifestyle
changes and by eating healthy food.
13
14

Contenu connexe

Tendances

Tendances (19)

Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis pathophysiology
Atherosclerosis pathophysiology Atherosclerosis pathophysiology
Atherosclerosis pathophysiology
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis and it’s complications
Atherosclerosis and it’s complicationsAtherosclerosis and it’s complications
Atherosclerosis and it’s complications
 
Artherosclerosis
ArtherosclerosisArtherosclerosis
Artherosclerosis
 
Introduction to atherosclerosis(slideshare)
Introduction to atherosclerosis(slideshare)Introduction to atherosclerosis(slideshare)
Introduction to atherosclerosis(slideshare)
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
atherosclerosis
atherosclerosisatherosclerosis
atherosclerosis
 
Atherosclerosis by neha
Atherosclerosis by nehaAtherosclerosis by neha
Atherosclerosis by neha
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
PAD- Atherosclerosis
PAD- Atherosclerosis PAD- Atherosclerosis
PAD- Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Arteriosclerosis 6
Arteriosclerosis 6Arteriosclerosis 6
Arteriosclerosis 6
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 

Similaire à Recent developments in the treatment of atherosclerosis

IHD ema_2020.pdf
IHD ema_2020.pdfIHD ema_2020.pdf
IHD ema_2020.pdf
Imtiyaz60
 
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular DegenerationAHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
Ancestral Health Society
 
Circulation 2014-melamed-e334-6
Circulation 2014-melamed-e334-6Circulation 2014-melamed-e334-6
Circulation 2014-melamed-e334-6
lunacovas
 

Similaire à Recent developments in the treatment of atherosclerosis (20)

Atherosclerosis
Atherosclerosis Atherosclerosis
Atherosclerosis
 
IHD ema_2020.pdf
IHD ema_2020.pdfIHD ema_2020.pdf
IHD ema_2020.pdf
 
Pathophysiology of atherosclerosis.pptx
Pathophysiology of atherosclerosis.pptxPathophysiology of atherosclerosis.pptx
Pathophysiology of atherosclerosis.pptx
 
blood lipids.docx
blood lipids.docxblood lipids.docx
blood lipids.docx
 
Lect 2 Hypercholesterolemia and Atherosclerosis
Lect 2 Hypercholesterolemia and AtherosclerosisLect 2 Hypercholesterolemia and Atherosclerosis
Lect 2 Hypercholesterolemia and Atherosclerosis
 
Hyperlipidemia
HyperlipidemiaHyperlipidemia
Hyperlipidemia
 
Cholesterol
CholesterolCholesterol
Cholesterol
 
17970_27.1Atherosclerosis.pptx
17970_27.1Atherosclerosis.pptx17970_27.1Atherosclerosis.pptx
17970_27.1Atherosclerosis.pptx
 
atherosclerosis.pptx
atherosclerosis.pptxatherosclerosis.pptx
atherosclerosis.pptx
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
Cad
CadCad
Cad
 
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular DegenerationAHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
AHS11 Chris Masterjohn - Heart Disease and Macular Degeneration
 
ARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptxARTERIOSCLEROSIS.pptx
ARTERIOSCLEROSIS.pptx
 
New microsoft word document (2)
New microsoft word document (2)New microsoft word document (2)
New microsoft word document (2)
 
Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology Lecture 7 diseases of the vascular system - Pathology
Lecture 7 diseases of the vascular system - Pathology
 
Atherosclerosis ppt
Atherosclerosis pptAtherosclerosis ppt
Atherosclerosis ppt
 
Circulation 2014-melamed-e334-6
Circulation 2014-melamed-e334-6Circulation 2014-melamed-e334-6
Circulation 2014-melamed-e334-6
 
lipid-lowering drugs
lipid-lowering drugslipid-lowering drugs
lipid-lowering drugs
 
Atherosclerosis
AtherosclerosisAtherosclerosis
Atherosclerosis
 
The role of HDL cholesterol in preventing atherosclerotic disease
The role of HDL cholesterol in preventing atherosclerotic diseaseThe role of HDL cholesterol in preventing atherosclerotic disease
The role of HDL cholesterol in preventing atherosclerotic disease
 

Dernier

Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Dernier (20)

Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptxExploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
Exploring_the_Narrative_Style_of_Amitav_Ghoshs_Gun_Island.pptx
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
Fostering Friendships - Enhancing Social Bonds in the Classroom
Fostering Friendships - Enhancing Social Bonds  in the ClassroomFostering Friendships - Enhancing Social Bonds  in the Classroom
Fostering Friendships - Enhancing Social Bonds in the Classroom
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
Beyond_Borders_Understanding_Anime_and_Manga_Fandom_A_Comprehensive_Audience_...
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Interdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptxInterdisciplinary_Insights_Data_Collection_Methods.pptx
Interdisciplinary_Insights_Data_Collection_Methods.pptx
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 

Recent developments in the treatment of atherosclerosis

  • 1. RECENT DEVELOPMENTS IN THE TREATMENTS OF ATHEROSCLEROSIS. 1
  • 2. WHAT IS ATHEROSCLEROSIS?  Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries become narrowed and hardened due to an excessive build up of plaque around the artery wall.The disease disrupts the flow of blood around the body, posing serious cardiovascular complications. 2
  • 3. WHY SHOULD WE KNOW ABOUT ATHEROSCLEROSIS?  Statins are highly effective in lowering low- density lipoprotein (LDL) cholesterol levels, and therefore represent the first-line treatment for prevention of cardiovascular disease. Despite this, a substantial proportion (>50%) of high-risk patients do not meet guideline targets for LDL cholesterol reduction.This clearly indicates an unmet need for additional treatment to improve LDL goal achievement. 3
  • 4.  Although atherosclerosis usually manifests in later life, its early phases are present in teenagers and young adults.  The clinical manifestations of atherosclerosis, such as CVD, are common in Western and urban populations, and are an important and common cause of death and disease.  Statins produce significant toxicity at high doses in a variety of animal species. 4
  • 5.  Effects can be prevented by administering mevalonate, the product of the reaction catalysed by HMG-CoA reductase.This indicates that these toxic effects are mostly, if not entirely, attributable to extreme inhibition of the enzyme at high doses.  The risk of myopathy with statins is increased by concomitant administration of certain other drugs, particularly gemfibrozil and to a lesser extent, possibly some other fibrates, and niacin. 5
  • 6. 6
  • 7. TREATMENT:  1)HDL usage : Boosting HDL cholesterol’s role as an ally against heart disease. However, the failure and increased mortality rates of one HDL-raising trial drug, torcetrapib, in 2006 highlights the challenges of discovering the right therapy. 7
  • 8.  It has raised concerns that maybe it’s not raising the right kinds of HDL. All forms of LDL are bad, HDL is a much more complicated story.HDL is called the “good cholesterol,” but in truth, HDL particles vary in size and composition, and we don’t know if all forms of HDL are good. 8
  • 9. 9  2)Anti inflammatories: Inflammation plays a key role in plaque formation and subsequent plaque rupture, which can lead to a heart attack. Statins along with lowering LDL cholesterol have anti inflammatory effect which help in preventing the atheromatous plaque rupture.  But, we have to develop entirely new types of drugs that specifically prevent or reduce inflammation in artery walls, by attacking root causes.
  • 10. Immunotherapeutic approaches: 1) Lipid BasedVaccines: This approach involves the inhibition of atherosclerotic lesion formation, associated with increased CETP antibodies, decreased CETP activity, and modified lipoprotein profiles. 10
  • 11.  2)VaccinationStrategies Based on Epitopes of Oxidized LDL: The different epitopes of oxidized LDL (oxLDL) induce atherogenic immune responses.This is an effective tool for modulation of the immune response to oxLDL.Also, a number of studies have shown that immunization against oxLDL reduces atherosclerosis. 11
  • 12.  Immunization with a peptide of apoB-100 (p210) fused to the B subunit of cholera toxin (CTB), which binds to a ganglioside on mucosal epithelia for 12 weeks, caused a 35% reduction in aortic lesion size in atherosclerosis-prone apoE-deficiency.  3) Heat Shock Proteins:Autoimmunity to heat shock proteins (HSPs) is one element in atherosclerosis- induced immune responses. Repeated mucosal administration of Mycobacterium HSP60/65, both orally and nasally, inhibited atherosclerotic lesion formation in LDL-receptor-deficient mice. 12
  • 13. CONCLUSION:-  In order to reduce further myocardial deaths we have to find safer and effective treatments methods against atherosclerosis and thereby reducing mortality and morbidity.  Right drug for the given condition.  Atherosclerosis can be prevented by lifestyle changes and by eating healthy food. 13
  • 14. 14

Notes de l'éditeur

  1. mm